Neither company disclosed deal terms. Sources told The Wall Street Journal it amounted to US$75 million in cash and stock. Good Chemistry CEO Arman Zaribafiyan will become head of product for SandboxAQ’s simulation platform, the companies said in a release. (The Logic, The Wall Street Journal)

Talking point: Clients use Good Chemistry’s cloud infrastructure and algorithms to predict how chemicals they’re considering for life- and materials-science applications will behave. The firm spun out of 1QBit, the Vancouver-based quantum software firm, in April 2022, inheriting marquee clients like industrial giant Dow. SandboxAQ has raised US$500 million to date, according to PitchBook data. Good Chemistry’s technology will bolster its new parent’s material-science functionality for drug discovery and other applications, even as SandboxAQ sells its own quantum cryptography and sensing products to its new acquisition’s customer base. Good Chemistry also brings its IP: the firm has 12 pending patent applications in three families, per PitchBook.